Evidence map›Paper›PMID 41603055›Full record

ArticleBrain and behavior2026

Lipopolysaccharide Upregulates Neuroinflammation, Oxidative Stress Responses, and Peroxiredoxins in Depression Models.

Zhifang Zhang, Nanshi Li, Mingkun Liang, Fangyan Qin, Qijing Qin, Qing He, Kaihua Wang, Xueli Shi, Ying Jiang, Hui Qin

Abstract read
In one paragraph

Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhifang ZhangDepartment of Neurology, Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0005-0982-8474
Nanshi LiMental Health Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0008-4979-0265
Mingkun LiangDepartment of Neurology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0000-0002-3854-6434
Fangyan QinDepartment of Neurology, Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0002-3709-3215
Qijing QinDepartment of Neurology, Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0004-8350-6361
Qing HeDepartment of Neurology, Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0005-7062-3494
Kaihua WangDepartment of Neurology, Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0000-0002-9199-8931
Xueli ShiGuangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0004-4924-613X
Ying JiangDepartment of Neurology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0009-3726-5698
Hui QinDepartment of Neurology, Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0006-7246-8384

Funding

Guangxi Natural Science FoundationGuangxi Natural Science Foundation Project 2025GXNSFAA069385Guangxi Universities Young and Middle-aged Teachers Basic Research Ability Improvement ProjectGuangxi University of Chinese Medicine Doctoral Research Start-up Fund ProjectKey Project of Guangxi Natural Science FoundationNational Traditional Chinese Advantageous Specialties Construction Unit-Zhuang Medical Brain Disease DepartmentScientific Research Start-up Fund for Introduced Talents of Guangxi International Zhuang Medicine Hospital
6 · The paper itself

Abstract

introductionDepression is a chronic psychiatric disorder and belongs to one of the leading causes of suicide worldwide. Peroxiredoxins (Prdxs) play a critical role in scavenging excess reactive oxygen species (ROS) and mitigating oxidative stress. However, the role and underlying mechanisms of Prdxs in depression have not been fully illustrated.

methodsWe carried out lipopolysaccharide (LPS)-induced ICR depression mice and BV2 cell inflammation models. Seven days after LPS-induction, behaviors in ICR mice were assessed by open field test (OFT), sucrose preference test (SPT), and forced swim test (FST), and inflammatory factors levels in serum were quantified via ELISA. The expression levels of Prdxs were evaluated using immunohistochemistry (IHC), western blotting (WB), and RT-qPCR. In LPS-induced BV2 cells, inflammatory factor levels in the supernatant were measured by ELISA. Nitric oxide (NO) levels were detected by biochemical assay. ROS levels were detected via fluorescence signal intensity. Prdxs expression levels were analyzed using WB and RT-qPCR.

resultsIn LPS-induced ICR mice serum and BV2 cells supernatant, interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and transforming growth factor-beta1 (TGF-β1) levels exhibited significant elevation (p < 0.05). In the hippocampus region of LPS-induced mice and LPS-induced BV2 cells, significant upregulation of Prdx1, Prdx2, Prdx4, and Prdx5 levels was observed (p < 0.05). The ROS and NO levels in LPS-induced BV2 cells also significantly increased (p < 0.05).

conclusionsThis study revealed that Prdx1, Prdx2, Prdx4, and Prdx5 were elevated in depression models, which might relate to the occurrence of neuroinflammation, coupled with upregulation of oxidative stress responses. This study provided new strategies for the treatment of depression.

Indexed as

DepressionLipopolysaccharidesNeuroinflammatory DiseasesOxidative StressPeroxiredoxinsAnimalsDisease Models, AnimalHippocampusInflammationMaleMiceMice, Inbred ICRReactive Oxygen SpeciesUp-RegulationLipopolysaccharidesPeroxiredoxinsReactive Oxygen Speciesdepressionlipopolysaccharideneuroinflammationoxidative stress responsesperoxiredoxins

Identifiers

PMID41603055
PMCPMC12848523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.